yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.
.
"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust.
.
.
.